Coronavirus vaccine 'Covishield' shows no adverse effects so
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
The late-phase human clinical trials of the Oxford-AstraZeneca vaccine, which is also known as 'Covishield' in India, have been running smoothly in India and have not shown any adverse side-effects so far.

Covishield, is currently in Phase 2 and Phase 3 human clinical trials in the country.

Phase-III human clinical trial of the coronavirus vaccine being developed by Oxford University, and manufactured by the Serum Institute of India (SII), began at the Sassoon General Hospital in Pune on September 17.

King Edward Memorial (KEM) Hospital in Mumbai on September 23 began the phase II and III trials of the coronavirus vaccine.

Some participants in the trials have also received their second doses and have not reported any adverse side-effects.

However, some did develop a fever after the dose of the coronavirus vaccine candidate but, "this is a mild reaction and nothing to get alarmed about", a top scientist, involved in the procedure said.

Source: https://www.indiatoday.in/india/story/coronavirus-vaccine-covishield-shows-no-adverse-effects-so-far-temp-1727536-2020-10-02
3 shares
Like
Comment
Share